May 16, 2008 (updated 5/13/2008)
This site was built to comply to Web authoring standards, and is best viewed in a standards-compliant browser. You may download one free from Netscape or Microsoft. You do not need to download a new browser, however, to have complete access to all information in this site.
Hollis-Eden Pharmaceuticals Provides Update on Clinical Development Programs; Announces First Quarter 2008 Financial Results >>
Hollis-Eden Pharmaceuticals to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference >>
Hollis-Eden Pharmaceuticals Schedules First Quarter 2008 Conference Call and Webcast >>
Hollis-Eden Pharmaceuticals Presents Positive Data with APOPTONE(TM) in Preclinical Bone Model of Late-Stage Prostate Cancer >>
Hollis-Eden Pharmaceuticals Reports Positive Preliminary Data from Ongoing Phase I/II Clinical Trial with TRIOLEX(TM) in Obese Insulin Resistant Subjects >>
Hollis-Eden Pharmaceuticals Provides Update on Clinical Development Program; Announces Fourth Quarter and Year-End 2007 Financial Results >>
 | 1st Quarter 2008 Conference Call |
Hollis-Eden 1st quarter 2008 financial results and development program conference call and webcast scheduled for May 13, 2008. Click here for details. >> | |
| Investor Conference Webcast |
Hollis-Eden to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference on May 20, 2008. Click here for webcast of presentation. >> | |
